Andrea Celotti
Andrea Celotti publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Oncology, on topics such as Pancreatic and Hepatic Oncology Research, Gallbladder and Bile Duct Disorders and Gastric Cancer Management and Outcomes.
- World rank
- #990,320 of 7,710,434 ranked researchers
- Rank in Italy
- #30,936 of 242,206
- Works
- 85
- Citations
- 1.4k
- Citations per work
- 16.3
What does Andrea Celotti research?
Andrea Celotti's work is mostly in Medicine (80%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6880.0%
- Medicine6880.0%
- Everything else1720.0%
- 1Surgery34% of their works
- 2Pulmonary and Respiratory Medicine21% of their works
- 3Oncology15% of their works
- 4Emergency Medicine4% of their works
- 5Hepatology4% of their works
- 6Epidemiology2% of their works
Research topics
- Pancreatic and Hepatic Oncology Research
- Gallbladder and Bile Duct Disorders
- Gastric Cancer Management and Outcomes
- Pancreatitis Pathology and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Colorectal Cancer Surgical Treatments
- Esophageal Cancer Research and Treatment
- Esophageal and GI Pathology
Which keywords describe Andrea Celotti's research?
The keywords of their largest research topics: Neoadjuvant Therapy, Chemotherapy, Epidemiology, Cholangiocarcinoma, Clinical Practice Guidelines, Endoscopic Resection, Preoperative Chemoradiotherapy and Pancreatic Cancer.
- Esophageal Perforation
- Endoscopic Stenting
- Adjuvant Chemotherapy
- Chronic Pancreatitis
- Acute Pancreatitis
- Gastric Cancer
- Cholecystitis
- Pancreatic Cancer
- Endoscopic Resection
- Cholangiocarcinoma
- Chemotherapy
- Neoadjuvant Therapy
- Epidemiology
- Clinical Practice Guidelines
- Preoperative Chemoradiotherapy
- Surgical Complications
- ERCP
- Molecular Characterization
- Biliary Tract Cancer
- Intrahepatic Cholangiocarcinoma
- Barrett's Esophagus
- Esophageal Carcinoma
- Rectal Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Neoadjuvant Therapy263 topics
- Chemotherapy232 topics
- Epidemiology233 topics
- Cholangiocarcinoma192 topics
- Clinical Practice Guidelines182 topics
- Endoscopic Resection182 topics
- Preoperative Chemoradiotherapy142 topics
- Pancreatic Cancer121 topic
- Surgical Complications121 topic
- Cholecystitis111 topic
- ERCP111 topic
- Gastric Cancer111 topic
- Molecular Characterization111 topic
- Acute Pancreatitis81 topic
- Biliary Tract Cancer81 topic
- Chronic Pancreatitis81 topic
- Intrahepatic Cholangiocarcinoma81 topic
- Adjuvant Chemotherapy71 topic
- Barrett's Esophagus71 topic
- Endoscopic Stenting71 topic
- Esophageal Carcinoma71 topic
- Esophageal Perforation71 topic
- Rectal Cancer71 topic
Where does Andrea Celotti work?
Andrea Celotti's main affiliation in the publication record is Istituti Ospitalieri di Cremona, Italy.
How many publications and citations does Andrea Celotti have?
OpenAlex counts 85 works and 1,389 citations for Andrea Celotti, an h-index of 17, ranking #990,320 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Andrea Celotti. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.